Feasibility of Asian and Middle Eastern markets for the suitability of Nexa's Negative Pressure Wound Therapy

Nexa医疗有限公司计划对其医疗器械Nexa负压伤口疗法出口到亚洲和中东地区的特定国家进行可行性研究。作为一家总部位于英国的公司，商业化的重点一直是英国市场。随着最近英国分销协议的成功，Nexa希望将其产品出口到具有商业利益的其他市场。亚洲和中东市场的负压伤口治疗有着非凡的增长，但它需要专业的帮助和知识才能进入这些市场。可行性研究将旨在回答有关向这些市场出口和销售的监管、分销和商业问题。重点国家是新加坡、马来西亚、泰国、沙特阿拉伯、科威特和阿拉伯联合酋长国。Nexa Medical拥有基于核心专利技术的计划产品线，但需要市场特定信息来满足技术和用户要求，以确保完全满足客户需求。该可行性项目的一个关键目标是通过与不同市场的医疗保健和销售专业人员接触，以正式的方式收集这些信息。

Nexa Medical Limited plans to undertake a feasibility study into the export of its medical device, Nexa Negative Pressure Wound Therapy, to specific countries in the Asian and Middle Eastern territories. As a UK based company, the commercialisation focus has been on the UK market. With the success of a recent UK distribution agreement, Nexa wants to export its products to other markets that are of commercial interest. The Asian and Middle East markets have exceptional growth of negative pressure wound therapy, but it requires specialist help and knowledge to access these markets. The feasibility study will aim to answer regulatory, distribution and commercial questions about exporting and selling into these markets. The countries of focus are Singapore, Malaysia, Thailand, Saudi Arabia, Kuwait and the United Arab Emirates.Nexa Medical has a planned product pipeline based on the core patented technology but market specific information is required to feed into the technical and user requirements in order to ensure the customer needs are fully met. A key goal of this feasibility project is to collect this information in a formal way by engaging with healthcare and sales professionals in the different markets.